VLP vaccine (Saiba)

N/A

Report date: 2025/01/26 16:48:00

Base Information

Drug NameVLP vaccine (Saiba)
Drug Alias NameSARS-CoV-2 vaccine (Saiba)virus-like particle vaccine (Saiba)
ClassificationBiologics > Protein drugs > Recombinant proteinVaccines > Application > Prophylactic vaccine
Mechanisms of ActionCoronavirus spike glycoprotein modulators
TargetsCoronavirus spike glycoprotein
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSaiba GmbH
China Registration ClassN/A

Develop Information

Active CompaniesSaiba GmbH
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A